Pliant Therapeutics Inc (PLRX)
11.81
-0.07
(-0.59%)
USD |
NASDAQ |
Apr 26, 16:00
11.81
0.00 (0.00%)
After-Hours: 19:17
Pliant Therapeutics Total Assets (Quarterly): 512.15M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 512.15M |
| September 30, 2023 | 540.46M |
| June 30, 2023 | 574.89M |
| March 31, 2023 | 597.88M |
| December 31, 2022 | 350.61M |
| September 30, 2022 | 377.18M |
| June 30, 2022 | 184.62M |
| March 31, 2022 | 197.02M |
| December 31, 2021 | 221.22M |
| Date | Value |
|---|---|
| September 30, 2021 | 234.12M |
| June 30, 2021 | 255.72M |
| March 31, 2021 | 275.25M |
| December 31, 2020 | 295.53M |
| September 30, 2020 | 312.32M |
| June 30, 2020 | 328.80M |
| March 31, 2020 | 184.06M |
| December 31, 2019 | 119.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
119.06M
Minimum
Dec 2019
597.88M
Maximum
Mar 2023
327.11M
Average
295.53M
Median
Dec 2020
Total Assets (Quarterly) Benchmarks
| Masimo Corp | 3.042B |
| Liquidia Corp | 118.33M |
| Vor Biopharma Inc | 198.13M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 38.58M |
| Shareholders Equity (Quarterly) | 473.58M |